vs

Side-by-side financial comparison of BIOMERICA INC (BMRA) and Professional Diversity Network, Inc. (IPDN). Click either name above to swap in a different company.

Professional Diversity Network, Inc. is the larger business by last-quarter revenue ($1.7M vs $1.2M, roughly 1.4× BIOMERICA INC). BIOMERICA INC runs the higher net margin — -109.1% vs -173.5%, a 64.4% gap on every dollar of revenue. On growth, Professional Diversity Network, Inc. posted the faster year-over-year revenue change (3.1% vs -26.0%). Over the past eight quarters, Professional Diversity Network, Inc.'s revenue compounded faster (-1.7% CAGR vs -12.1%).

Biomerica Inc. is a global medical technology company that develops, manufactures and markets diagnostic test kits and related medical products. Its portfolio covers gastrointestinal conditions, infectious diseases, food intolerances and point-of-care testing solutions, serving clinical labs, healthcare providers and retail healthcare segments across North America, Europe and Asia.

Professional Diversity Network, Inc. is a U.S.-based firm offering end-to-end diversity, equity and inclusion (DEI) solutions for corporate clients. Its services include targeted recruitment support for underrepresented talent groups, customized DEI training programs, and diversity performance data analytics, serving clients across tech, healthcare, finance and other core commercial sectors nationwide.

BMRA vs IPDN — Head-to-Head

Bigger by revenue
IPDN
IPDN
1.4× larger
IPDN
$1.7M
$1.2M
BMRA
Growing faster (revenue YoY)
IPDN
IPDN
+29.1% gap
IPDN
3.1%
-26.0%
BMRA
Higher net margin
BMRA
BMRA
64.4% more per $
BMRA
-109.1%
-173.5%
IPDN
Faster 2-yr revenue CAGR
IPDN
IPDN
Annualised
IPDN
-1.7%
-12.1%
BMRA

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
BMRA
BMRA
IPDN
IPDN
Revenue
$1.2M
$1.7M
Net Profit
$-1.3M
$-2.9M
Gross Margin
4.2%
33.7%
Operating Margin
-113.5%
-173.2%
Net Margin
-109.1%
-173.5%
Revenue YoY
-26.0%
3.1%
Net Profit YoY
-38.9%
-280.0%
EPS (diluted)
$-0.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BMRA
BMRA
IPDN
IPDN
Q4 25
$1.2M
$1.7M
Q3 25
$1.4M
$1.7M
Q2 25
$1.6M
Q1 25
$1.1M
$1.5M
Q4 24
$1.6M
$1.6M
Q3 24
$1.8M
$1.7M
Q2 24
$1.1M
$1.7M
Q1 24
$1.0M
$1.7M
Net Profit
BMRA
BMRA
IPDN
IPDN
Q4 25
$-1.3M
$-2.9M
Q3 25
$2.0K
$-2.4M
Q2 25
$-476.0K
Q1 25
$-1.2M
$-722.1K
Q4 24
$-950.0K
$-761.9K
Q3 24
$-1.3M
$-405.0K
Q2 24
$-1.4M
$-553.1K
Q1 24
$-1.9M
$-791.8K
Gross Margin
BMRA
BMRA
IPDN
IPDN
Q4 25
4.2%
33.7%
Q3 25
30.7%
44.0%
Q2 25
43.4%
Q1 25
1.7%
52.2%
Q4 24
26.7%
58.6%
Q3 24
16.0%
58.9%
Q2 24
2.1%
62.9%
Q1 24
-14.7%
62.2%
Operating Margin
BMRA
BMRA
IPDN
IPDN
Q4 25
-113.5%
-173.2%
Q3 25
-81.0%
-136.3%
Q2 25
-30.2%
Q1 25
-108.1%
-46.9%
Q4 24
-60.7%
-36.8%
Q3 24
-75.7%
-25.0%
Q2 24
-136.6%
-34.4%
Q1 24
-196.7%
-46.5%
Net Margin
BMRA
BMRA
IPDN
IPDN
Q4 25
-109.1%
-173.5%
Q3 25
0.1%
-136.2%
Q2 25
-29.0%
Q1 25
-103.9%
-48.0%
Q4 24
-58.1%
-47.1%
Q3 24
-72.8%
-23.9%
Q2 24
-127.1%
-32.7%
Q1 24
-188.6%
-45.9%
EPS (diluted)
BMRA
BMRA
IPDN
IPDN
Q4 25
$-0.45
Q3 25
$0.00
Q2 25
Q1 25
$-0.48
Q4 24
$-0.06
Q3 24
$-0.63
Q2 24
$-2.57
Q1 24
$-0.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BMRA
BMRA
IPDN
IPDN
Cash + ST InvestmentsLiquidity on hand
$2.5M
$217.0K
Total DebtLower is stronger
Stockholders' EquityBook value
$4.4M
$11.7M
Total Assets
$6.0M
$17.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BMRA
BMRA
IPDN
IPDN
Q4 25
$2.5M
$217.0K
Q3 25
$3.1M
$265.3K
Q2 25
$125.1K
Q1 25
$3.1M
$496.4K
Q4 24
$2.4M
$1.7M
Q3 24
$2.8M
$133.7K
Q2 24
$4.2M
$619.3K
Q1 24
$5.3M
$97.1K
Stockholders' Equity
BMRA
BMRA
IPDN
IPDN
Q4 25
$4.4M
$11.7M
Q3 25
$5.2M
$8.9M
Q2 25
$4.5M
Q1 25
$5.5M
$4.9M
Q4 24
$5.1M
$5.3M
Q3 24
$5.3M
$2.1M
Q2 24
$6.6M
$2.5M
Q1 24
$7.8M
$2.3M
Total Assets
BMRA
BMRA
IPDN
IPDN
Q4 25
$6.0M
$17.9M
Q3 25
$6.9M
$12.1M
Q2 25
$7.3M
Q1 25
$7.4M
$7.7M
Q4 24
$7.3M
$8.0M
Q3 24
$7.9M
$5.3M
Q2 24
$9.3M
$5.8M
Q1 24
$10.3M
$5.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BMRA
BMRA
IPDN
IPDN
Operating Cash FlowLast quarter
$-991.0K
$1.4M
Free Cash FlowOCF − Capex
$1.4M
FCF MarginFCF / Revenue
84.4%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BMRA
BMRA
IPDN
IPDN
Q4 25
$-991.0K
$1.4M
Q3 25
$-268.0K
$-2.7M
Q2 25
$-495.5K
Q1 25
$-1.0M
$-284.1K
Q4 24
$-791.0K
$-1.2M
Q3 24
$-1.3M
$-556.9K
Q2 24
$-1.0M
$-224.4K
Q1 24
$-1.8M
$-543.1K
Free Cash Flow
BMRA
BMRA
IPDN
IPDN
Q4 25
$1.4M
Q3 25
$-2.7M
Q2 25
$-499.5K
Q1 25
Q4 24
$-1.2M
Q3 24
$-558.9K
Q2 24
$-1.1M
$-225.9K
Q1 24
$-543.6K
FCF Margin
BMRA
BMRA
IPDN
IPDN
Q4 25
84.4%
Q3 25
-156.8%
Q2 25
-30.4%
Q1 25
Q4 24
-74.0%
Q3 24
-33.0%
Q2 24
-95.5%
-13.4%
Q1 24
-31.5%
Capex Intensity
BMRA
BMRA
IPDN
IPDN
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.2%
Q1 25
0.0%
Q4 24
1.3%
Q3 24
0.1%
Q2 24
2.1%
0.1%
Q1 24
0.0%
0.0%
Cash Conversion
BMRA
BMRA
IPDN
IPDN
Q4 25
Q3 25
-134.00×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons